Dapagliflozin vs Metformin
Dapagliflozin vs Metformin: Overview
This comparison examines the pharmacological differences between Dapagliflozin and Metformin.
Mechanism of Action
Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Dapagliflozin β 12.9 hours; Metformin β 4-9 hours.
Chemical Properties
Molecular Formula: Dapagliflozin β C21H25ClO6; Metformin β C4H11N5.
Molecular Weight: Dapagliflozin β 408.8730 g/mol; Metformin β 129.1640 g/mol.
Type: Dapagliflozin β Small molecule; Metformin β Small molecule.